Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Aprroaches to reducing the cardiovascular risk in the late periods of ischemic stroke

https://doi.org/10.14412/2074-2711-2010-109

Full Text:

Abstract

Basic antihypertensive, antithrombotic, and antihyperlipidemic therapies form the basis for the prevention of cardiovascular events after
ischemic stroke (IS). It is necessary, if indicated, to perform reparative operations on the brachiocephalic arteries. A package of measures to
improve the prognosis of a late poststroke period should include the timely detection and adequate therapy of cardiac pathology and the consideration
of the predictors of its increased risk. A prospective follow-up of 133 patients with prior IS was conducted to study the prognostic
factors of cardiac events in the late poststroke period. During the follow-up, 12 (9%) patients experienced cardiac events, 5 of them died. The
outpatient basic treatment of these patients was inadequate. The predictors of poor cardiac prognosis were elderly and senile age, the presence
of coronary heart disease, paroxysmal atrial fibrillation, life-threatening ventricular arrhythmias, and reduced heart rhythm variability.

References

1. <div><p>Инсульт: диагностика, лечение, профилактика. Под. ред. З.А. Суслиной, М.А. Пирадова. М.: МЕДпресс-информ, 2009;288 с.</p><p>Суслина З.А., Варакин Ю.Я., Верещагин Н.В. Сосудистые заболевания головного мозга: Эпидемиология. Патогенетические механизмы. Профилактика. М.: МЕДпресс-информ, 2009;352 с.</p><p>Ворлоу Ч.П., Деннис М.С., ван Гейн Ж. и др. Инсульт. Практическое руководство для ведения больных. СПб., 1998.</p><p>Lawes C.M., Bennett D.A., Feigin V.L. et al. Blood pressure and stroke: an overview of published reviews. Stroke 2004;35:145-53.</p><p>Rodgers A., MacMahon S., Gamble G. et al. Blood pressure and risk of stroke in patients with cerebrovascular disease: the United Kingdom Transient Ischemic Attack Collaborative Group. BMJ 1996;313:147.</p><p>uidelines for prevention of stroke in patients wSacco R.L., Adams R., Albers G. et al. Gith ischemic stroke or transient ischemic attack. AHA/ASA Guideline. Stroke 2006;37:577-617.</p><p>The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attacks 2008. Cerebrovasc Dis 2008;25:457-507.</p><p>Carter A.B. Hypotensive therapy in stroke survivors. Lancet 1970;295:485-9. 9.</p><p>PATS Collaborating Group. Post-Stroke Antihypertensive Treatment Study: a preliminary result. Chin Med J 1995;108:710-7.</p><p>PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.</p><p>Schrader J.S., Luders S., Kulschewski A. et al. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention principal results of a prospective randomized controlled study (MOSES). Stroke 2005;36:1218-26.</p><p>Суслина З.А., Фонякин А.В., Гераскина Л.А. и др. Практическая кардионеврология. М.: ИМА-ПРЕСС, 2010;302 с.</p><p>Amarenco P., Bogousslavsky J., Callahan A. 3rd et al., for the SPARCL investigators. Highdose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-59.</p><p>Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke: EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 1993;342:1255-62.</p><p>A randomized trial of aspirin and sulfinpyrazone in threatened stroke: the Canadian Cooperative Study Group. N Engl J Med 1978;299:53-9.</p><p>Antithrombotic Trialists` Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 2002;324:71-86.</p><p>Gorelick P.B., Richardson D., Kelly M. et al. Aspirin and ticlopidin for the prevention of recurrent stroke in black patients: a randomized trial. JAMA 2003;289:2947-57.</p><p>CAPRIE Steering Committee. A randomized, blinded trial of Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE). Lancet 1996;348:1329-39.</p><p>Diener H.C., Cunha L., Forbes C. et al. European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.</p><p>Sacco R.L., Diener H.C., Yusuf S. et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008;359:1238-51.</p><p>Hobson R.W., Mackey W.C., Ascher E. et al. Management of atherosclerotic carotid artery disease: Clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg 2008;48:480-6.</p><p>Liapis C.D., Sir Bell P.R.F., Mikhailidis D. et al., on behalf of the ESVS Guidelines Collaborators1. ESVS Guidelines. Invasive Treatment for Carotid Stenosis: Indications, Techniques. Eur J Vasc Endovasc Surg 2009;37:S1-S19.</p><p>Barnett H.J., Taylor D.W., Eliasziw M. et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998;339:1415-25.</p><p>Streifler J.Y., Eliasziw M., Benavente O.R. et al. The risk of stroke in patients with firstever retinal vs hemispheric transient ischemic attacks and high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol 1995;52:246-9.</p><p>Marks M., Marcellus M., Do H. et al. Primary angioplasty for symptomatic intracranial atherosclerotic stenosis: long term followup. Stroke 2004;35:258.</p><p>Meyers P.M., Schumacher H.C., Higashida R.T. et al. Indications for the Performance of Intracranial Endovascular Neurointerventional Procedures. A Scientific Statement From the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009;119:2235-49.</p><p>Рябова В.С. Отдаленные последствия мозгового инсульта (по материалам регистра). Журн невропатол и психиатр 1986;4:532-6.</p><p>Chimowitz M.I., Weiss D.G., Cohen S.L. et al. Cardiac prognosis of patients with carotid stenosis and no history of coronary artery disease. Stroke 1994;25:759-65.</p><p>Aronow W.S., Ahn C., Schoenfeld M.R. et al. Prognostic significance of silent myocardial ischemia in patients &gt;61 years of age with extracranial internal or common carotid arterial disease with and without previous myocardial infarction. Am J Cardiol 1993;71:115-7.</p><p>Wilterdink J.L., Furie K.L., Easton D. Cardiac evaluation of stroke patients. Neurology 1998;51(Suppl. 3):S23-S26.</p><p>Голухова Е.З. Неинвазивная аритмология. М.: Изд-во НЦССХ им. А.Н. Бакулева, 2002;148 с.</p><p>Rashid R., Leonardi-Bee J., Bath Ph. Blood pressure reduction and secondary prevention of stroke and other vascular events. A systematic review. Stroke 2003;34:2741-9.</p><p>The Dutch TIA Study Group. Trial of secondary prevention with atenolol after transient ischemic attack or no disabling ischemic stroke. Stroke 1993;24:543-8.</p><p>The Heart Outcome Prevention Evaluation Study Investigators. Effects of an angiotensinconverting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;358:1033-41.</p><p>Oppenheimer S., Norris J.W. Cardiac manifestations of acute neurological lesions. In: Neurosonology and General medicine: The neurological aspects of medical disorders (ed. M.J.Aminoff ), 2nd ed. New York: Churchill- Livingstone, 1995;183-200.</p><p>Sander D., Klingelhofer J. Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction. Stroke 1994;25:1730-7.</p><p>Рябыкина Г.В., Соболев А.В. Вариабельность ритма сердца. М., 1998.</p><p>Lown B., Verrier R.L. Neural activity and ventricular fibrillation. N Engl J Med 1976;294:1165-70.</p></div><br />


For citation:


Fonyakin A.V., Geraskina L.A., Shandalin V.A., Fonyakin A.V., Geraskina L.A., Shandalin V.A. Aprroaches to reducing the cardiovascular risk in the late periods of ischemic stroke. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(4):5-11. (In Russ.) https://doi.org/10.14412/2074-2711-2010-109

Views: 385


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)